This inventor holds 2 USPTO granted patents. Top assignee: Piramal Life Sciences Limited. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Vadlamudi V S V Rao: Innovator in Pharmaceutical Sciences
Introduction
Vadlamudi V S V Rao is a prominent inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds that target critical biological processes. With a total of 2 patents to his name, Rao's work is recognized for its potential impact on medical treatments.
Latest Patents
Rao's latest patents include innovations related to fibrinogen receptor antagonists. These inventions focus on novel fused bicyclic compounds that serve as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex. The compounds are designed to inhibit platelet aggregation, making them useful for the treatment of thrombotic diseases and other related conditions. The patents also cover pharmaceutical compositions containing these compounds, processes for their preparation, and methods of use, either alone or in combination with other therapeutic agents.
Career Highlights
Vadlamudi V S V Rao is associated with Piramal Life Sciences Limited, where he continues to advance his research and development efforts. His work in the pharmaceutical industry has positioned him as a key player in the innovation of therapeutic solutions.
Collaborations
Rao has collaborated with notable colleagues, including Bansi Lal and Ashok Kumar Gangopadhyay, to further enhance the scope and impact of his research. These collaborations have contributed to the successful development of his patented inventions.
Conclusion
Vadlamudi V S V Rao's contributions to pharmaceutical sciences through his innovative patents highlight his role as a significant inventor in the field. His work not only advances medical treatments but also showcases the importance of collaboration in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
